Hydrogenology
Source-linked study record

Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment

Nishimaki K et al. · Curr Alzheimer Res. 2018;15(5):482–492.

HumanH₂-rich waterPublished 2018Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Human

Population or model

Older adults with mild cognitive impairment

Intervention and dose

One 500 mL pouch of hydrogen-rich water daily · More than 0.6 mM dissolved H₂ when supplied.

Duration

1 year

Reported result

Overall ADAS-cog did not differ significantly between groups. Favorable findings were reported in the small APOE4-carrier subgroup; average adherence was about 64%.

Main limitation

Eight randomized participants were excluded after randomization, adherence averaged 64%, and the positive interpretation relies on a very small genotype subgroup despite a null overall cognitive result. Water was supplied by Blue Mercury; one author had previously advised the company.

Evidence and classification

What kind of evidence is this?

Evidence type

Human

Reported design

Randomized double-blind placebo-controlled parallel clinical study with separate animal experiments

Research topic

Other neurological conditions

Administration form

H₂-rich water

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Older adults with mild cognitive impairment

Sample

81 randomized; 73 analyzed: H₂ water n=35 and placebo n=38

Duration

1 year

Intervention

One 500 mL pouch of hydrogen-rich water daily

Hydrogen form

H₂ dissolved in water — H₂ only, not Brown’s gas.

Dose or H₂ specification

More than 0.6 mM dissolved H₂ when supplied.

Comparator

Identically packaged placebo water, 500 mL/day

Reported, not endorsed

Outcomes and reported result

Outcomes measured

ADAS-cog and cognitive subscales, including exploratory APOE4-carrier analyses

Reported result

Overall ADAS-cog did not differ significantly between groups. Favorable findings were reported in the small APOE4-carrier subgroup; average adherence was about 64%.

Extraction completeness

Human dose, methods, full results, funding and conflicts checked in the open-access full text; independent appraisal remains incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Eight randomized participants were excluded after randomization, adherence averaged 64%, and the positive interpretation relies on a very small genotype subgroup despite a null overall cognitive result. Water was supplied by Blue Mercury; one author had previously advised the company.

Applies directly to

Older adults with mild cognitive impairment; the animal component is separate from the human trial.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 29110615 · DOI: 10.2174/1567205014666171106145017

Publisher access

Open-access full text is available through PMC.

Extraction basis

Open-access PMC full text and PubMed bibliographic record.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.